Compare · ELV vs EXAS
ELV vs EXAS
Side-by-side comparison of Elevance Health Inc. (ELV) and Exact Sciences Corporation (EXAS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and EXAS operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $80.92B, about 6.6x EXAS ($12.19B).
- Over the past year, ELV is up 34.6% and EXAS is up 108.0% - EXAS leads by 73.4 points.
- ELV has hit the wire 9 times in the past 4 weeks while EXAS has been quiet.
- EXAS has more recent analyst coverage (25 ratings vs 23 for ELV).
- Company
- Elevance Health Inc.
- Exact Sciences Corporation
- Price
- $372.94+0.02%
- $104.94+1.02%
- Market cap
- $80.92B
- $12.19B
- 1M return
- -6.26%
- +1.60%
- 1Y return
- +34.64%
- +108.05%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2001
- News (4w)
- 9
- 0
- Recent ratings
- 23
- 25
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Exact Sciences Corporation
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Latest ELV
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
- Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
- New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
- Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
- SEC Form 11-K filed by Elevance Health Inc.
Latest EXAS
- SEC Form 15-12G filed by Exact Sciences Corporation
- Amendment: SEC Form SCHEDULE 13G/A filed by Exact Sciences Corporation
- SEC Form POSASR filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation